Potential cell sources for tissue engineering of heart valves in comparison with human pulmonary valve cells

ASAIO Journal

Volumn 55, Issue 1, 2009, Pages 86-92

  Schaefermeier, Philipp K ^a   Cabeza, Natalia ^a   Besser, Jaya C ^a   Lohse, Peter ^b   Daebritz, Sabine H ^a   Schmitz, Christoph ^a   Reichart, Bruno ^a   Sodian, Ralf ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SOURCES; CURRENT TECHNIQUES; HEART VALVES; IN-VITRO; MYOFIBROBLAST; NOVEL TECHNIQUES; PEDIATRIC PATIENTS; PULMONARY HEART VALVE; SAPHENOUS VEIN; SMOOTH MUSCLES; UMBILICAL CORDS;

BIODEGRADABLE POLYMERS; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; CYTOLOGY; GENE EXPRESSION; HEART VALVE PROSTHESES; SELF ASSEMBLY; TISSUE ENGINEERING; VALVES (MECHANICAL);

ENDOTHELIAL CELLS;

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; BIOLOGICAL MARKER;

ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HEART VALVE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; LEYDIG CELL; MORPHOLOGY; MYOFIBROBLAST; PULMONARY VALVE; SAPHENOUS VEIN; TISSUE ENGINEERING; UMBILICAL ARTERY; COMPARATIVE STUDY; CYTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VALVULAR HEART DISEASE;

BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; GENE EXPRESSION; HEART VALVE DISEASES; HEART VALVES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PULMONARY VALVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; TISSUE ENGINEERING; UMBILICAL VEINS;

EID: 62449106070     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e31818f54e4     Document Type: Article

References (29)

1. Flanagan TC, Pandit A: Living artificial heart valve alternatives: A review. Eur Cell Mater 6: 28-45, 2003.
2. Schmidt D, Hoerstrup SP: Tissue engineered heart valves based on human cells. Swiss Med Wkly 135: 618-623, 2005.
3. Mayer J: Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Sem Thorac Cardiovasc Surg 7: 130-132, 1995.
4. Schoen FJ, Levy RJ: Founder's Award, 25th Annual Meeting of the Society for Biomaterials, perspectives. Providence, RI, Apri 28-May 2, 1999. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 47: 439-465, 1999.
5. Taylor PM, Batten P, Brand NJ, et al : The cardiac valve interstitial cell. Int J Biochem Cell Biol 35: 113-118, 2003.
6. Brody S, Pandit S: Approaches to heart valve tissue engineering scaffold design. J Biomed Mat Res 83: 16-43, 2007.
7. Schmidt D, Hoerstrup SP: Tissue engineered heart valves based on human cells. Swiss Med Wkly 135: 618-623, 2005.
8. Schmidt D, Achermann J, Odermatt B, et al: Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 116: I64-I70, 2007.
9. Sodian R, Lueders C, Kraemer L, et al: Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann Thorac Surg 81: 2207-2216, 2006.
10. Bader A, Schilling T, Teebken OE, et al: Tissue engineering of heart valves-human endothelial cell seeding of detergent acelularized porcine valves. Eur J Cardiothorac Surg 14: 279-284, 1998.
11. Kasimir MT, Weigel G, Sharma J, et al: The decellularized porcine heart valve matrix in tissue engineering: Platelet adhesion and activation. Thromb Haemost 94: 562-567, 2005.
12. Hoerstrup SP, Kadner A, Breymann C, et al: Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg 74: 46-52, 2002. 1 3. Hoerstrup SP, Zünd G, Cheng S, et al: A new approach to completely autologous cardiovascular tissue in humans. ASAIO J 48: 234-238, 2002.
13. van Wachem PB, Reinders JH, van Buul-Wortelboer MF, et al: Von Willebrand factor in cultured human vascular endothelia cells from adult and umbilical cord arteries and veins. Thromb Haemost 56: 189-192, 1986.
14. Desjardins F, Balligand JL: Nitric oxide-dependent endothelia function and cardiovascular disease. Acta Clin Belg 61: 326-334, 2006.
15. Muro S, Muzykantov VR: Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des 11: 2383-2401, 2005.
16. Ruggeri ZM: The role of von Willebrand factor in thrombus formation. Thromb Res 120 (Suppl 1): S5-S9, 2007.
17. Uhlenbrock K, Huber J, Ardati A, et al: Fluid shear stress differentially regulates gpr3, gpr6, and gpr12 expression in human umbilical vein endothelial cells. Cell Physiol Biochem 13: 75-84, 2003.
18. Si H, Heyken WT, Wolfle SE, et al: Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2 + activated K+ channel. Circ Res 99: 537-544, 2006.
19. Grgic I, Eichler I, Heinau P, et al: Selective blockade of the intermediate-conductance Ca2+-activated K+ channel suppresses proliferation of microvascular and macrovascular endothelial cells and angiogenesis in vivo. Arterioscler Thromb Vasc Biol 25: 704-709, 2005.
20. Latif N, Sarathchandra P, Taylor PM, et al: Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis 14:218-227, 2005.
21. Butcher JT, Simmons CA, Warnock JN: Mechanobiology of the aortic heart valve. J Heart Valve Dis 17: 62-73, 2008.
22. Shinoka T, Shum-Tim D, Ma PX, et al: Tissue-engineered heart valve leaflets: Does cell origin affect outcome? Circulation 96: I102-II107, 1997.
23. Sodian R, Hoerstrup SP, Sperling JS, et al: Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves. ASAIO 46: 107-110, 2000.
24. Schmidt D, Mol A, Breymann C, et al: Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 114: I125-II31, 2006.
25. Allen J, Khan S, Serrano MC, Ameer G: Characterization of Porcine Circulating Progenitor Cells: Toward a Functional Endothelium. Tissue Eng 14: 183-194, 2008.
26. Flanagan TC, Black A, O'Brien M, et al: Reference models for mitral valve tissue engineering based on valve cell phenotype and extracellular matrix analysis. Cells Tissues Organs 183: 12-23, 2006.
27. Kirkpatrick CJ, Otto M, Van Kooten T, et al: Endothelial cell cultures as a tool in biomaterial research. J Mater Sci Mater Med 10: 589-594, 1999.
28. Rabkin E, Hoerstrup SP, Aikawa M, et al: Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis 11: 308-314, 2002.
29. Neidert MR, Tranquillo RT: Tissue-engineered valves with commissural alignment. Tissue Eng 12: 891-903, 2006.